Bridgeway Capital Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bridgeway Capital Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,500	Closed	-$417K	–	1334
2024 Q3	$417K	Sell	12,500 -7,500	-38%	-$258K	0.01%	904
2024 Q2	$541K	Sell	20,000 -50,000	-71%	-$986K	0.01%	842
2024 Q1	$1.51M	Hold	70,000	–	–	0.03%	645
2023 Q4	$422K	Buy	70,000 +20,000	+40%	+$99.7K	0.01%	980
2023 Q3	$278K	Hold	50,000	–	–	0.01%	1026
2023 Q2	$367K	Hold	50,000	–	–	0.01%	994
2023 Q1	$197K	Buy	50,000 +25,000	+100%	+$122K	0.01%	1113
2022 Q4	$79K	Sell	25,000 -45,000	-64%	-$181K	﹤0.01%	1250
2022 Q3	$260K	Hold	70,000	–	–	0.01%	1081
2022 Q2	$216K	Hold	70,000	–	–	﹤0.01%	1079
2022 Q1	$363K	Hold	70,000	–	–	0.01%	1019
2021 Q4	$339K	Hold	70,000	–	–	0.01%	1075
2021 Q3	$624K	Buy	+70,000	New	+$646K	0.01%	972

Bridgeway Capital Management's LBPH Position: Q4 2024 in Review

Bridgeway Capital Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 12,500 shares — an estimated $417K sold.

Bridgeway Capital Management first reported a position in LBPH in Q3 2021 and held it in 13 quarters. The position peaked at $1.51M in Q1 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Bridgeway Capital Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Bridgeway Capital Management sold 12,500 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $417K.
Bridgeway Capital Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 13 quarters.
Bridgeway Capital Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.51M in Q1 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Bridgeway Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.